WO1996002532A1 - 7-substituierte 1-[4-(1h-1,2,4-triazol-1-yl-methyl)phenyl] substituierte chinoloncarbonsäuren als antivirale mittel - Google Patents

7-substituierte 1-[4-(1h-1,2,4-triazol-1-yl-methyl)phenyl] substituierte chinoloncarbonsäuren als antivirale mittel Download PDF

Info

Publication number
WO1996002532A1
WO1996002532A1 PCT/EP1995/002643 EP9502643W WO9602532A1 WO 1996002532 A1 WO1996002532 A1 WO 1996002532A1 EP 9502643 W EP9502643 W EP 9502643W WO 9602532 A1 WO9602532 A1 WO 9602532A1
Authority
WO
WIPO (PCT)
Prior art keywords
substituted
triazol
phenyl
methyl
carboxylic acids
Prior art date
Application number
PCT/EP1995/002643
Other languages
English (en)
French (fr)
Inventor
Wolfgang Bender
Wolfgang RÖBEN
Arnold Paessens
Stephan Bartel
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Priority to AU30763/95A priority Critical patent/AU3076395A/en
Publication of WO1996002532A1 publication Critical patent/WO1996002532A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die vorliegende Erfindung betrifft 7-substituierte 1-[4-(1H-1,2,4-triazol-1-yl-methyl)phenyl] substituierte Chinoloncarbonsäuren der allgemeinen Formel (I), wobei die Substituenten die in der Beschreibung angegebene Bedeutung haben, Verfahren zur ihrer Herstellung sowie ihre Verwendung als Arzneimittel, insbesondere als antivirale Mittel.
PCT/EP1995/002643 1994-07-20 1995-07-07 7-substituierte 1-[4-(1h-1,2,4-triazol-1-yl-methyl)phenyl] substituierte chinoloncarbonsäuren als antivirale mittel WO1996002532A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU30763/95A AU3076395A (en) 1994-07-20 1995-07-07 7-substituted 1-{4-(1h-1,2,4-triazol-1-yl-methyl)phenyl} substituted quinolone carboxylic acids as antiviral agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4425660.4 1994-07-20
DE4425660A DE4425660A1 (de) 1994-07-20 1994-07-20 7-substituierte 1-[4-(1H-1,2,4-triazol-1-yl-methyl)phenyl] substituierte Chinoloncarbonsäuren

Publications (1)

Publication Number Publication Date
WO1996002532A1 true WO1996002532A1 (de) 1996-02-01

Family

ID=6523667

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1995/002643 WO1996002532A1 (de) 1994-07-20 1995-07-07 7-substituierte 1-[4-(1h-1,2,4-triazol-1-yl-methyl)phenyl] substituierte chinoloncarbonsäuren als antivirale mittel

Country Status (5)

Country Link
AU (1) AU3076395A (de)
DE (1) DE4425660A1 (de)
IL (1) IL114619A0 (de)
WO (1) WO1996002532A1 (de)
ZA (1) ZA956012B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1805142A4 (de) 2004-09-23 2009-06-10 Reddy Us Therapeutics Inc Neue pyridinverbindungen, verfahren zu ihrer herstellung und zusammensetzungen damit

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0422485A2 (de) * 1989-10-12 1991-04-17 Bayer Ag Chinoloncarbonsäurederivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als antivirale Mittel
EP0572259A1 (de) * 1992-05-27 1993-12-01 Ube Industries, Ltd. Aminochinolonderivate als anti-HIV Wirkstoffe
DE4303657A1 (de) * 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0422485A2 (de) * 1989-10-12 1991-04-17 Bayer Ag Chinoloncarbonsäurederivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als antivirale Mittel
EP0572259A1 (de) * 1992-05-27 1993-12-01 Ube Industries, Ltd. Aminochinolonderivate als anti-HIV Wirkstoffe
DE4303657A1 (de) * 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate

Also Published As

Publication number Publication date
IL114619A0 (en) 1995-11-27
DE4425660A1 (de) 1996-01-25
AU3076395A (en) 1996-02-16
ZA956012B (en) 1996-02-22

Similar Documents

Publication Publication Date Title
BG101112A (en) The use of heterocyclic compounds
AU2777089A (en) Substituted pyrrole, pyrazole and triazole angiotensin 11 antagonists
CA2151674A1 (en) Methods of Administering CRF Antagonists
MX9702658A (es) Derivados novedosos de acido carboxilico, su preparacion y uso.
BG105783A (en) Triazole compounds with dopamine-d3-receptor affinity
AU3859999A (en) 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
CA2146852A1 (en) New substituted pyrazole derivatives, processes for their preparation and their use as herbicides
CA2268954A1 (en) Oxadiazoles, processes for their preparation and their use as medicaments
CA2269721A1 (en) 1-phenylpyrazole compounds and medicinal application thereof
AU3363993A (en) Amino acid derivatives as PAF antagonists
CA2165971A1 (en) Methylphosphonic acid ester, process for preparing the same and its use
CA2246753A1 (en) Non-peptidyl vasopressin v1a antagonists
CA2071601A1 (en) Fungicidal composition
MY131693A (en) Arylacetic acid derivatives
CA2237189A1 (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
EP0318083A3 (de) Pyridylalkancarbonsäure und ihre Verwendung als Arzneimittel
WO2001058875A3 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
CA2264005A1 (en) Piperazino derivatives as neurokinin antagonists
ZA956016B (en) Novel 6- and 6,8-substituted 1-[4-(1H-1,2,4-triazol-1-yl-methyl)phenyl]-quinolencarboxylic acids
CA2188796A1 (en) Heterocyclylbenzonitriles
WO1996002532A1 (de) 7-substituierte 1-[4-(1h-1,2,4-triazol-1-yl-methyl)phenyl] substituierte chinoloncarbonsäuren als antivirale mittel
GB9323162D0 (en) 4-(1h-2-methylimidazo(4,5-c)pyridinylmethyl)phenylsulphonamid e derivatives as antagonists of paf
CA2281702A1 (en) (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
EP0367069A3 (de) Substituierte Bisazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2001010861A3 (de) Substituierte heterocyclyl-2h-chromene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA CN CZ FI HU JP KR LT MX NO NZ PL RU SI SK US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)